Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does wellbutrin increase blood pressure?What are the risks of combining alcohol and lyrica?Will onglyza's cost decrease with generic launch?Do bulk vascepa purchases offer cost savings?Should patients be aware of any additional muscle related precaut when using lipitor and warfar statins?
See the DrugPatentWatch profile for prolia
Does Prolia cause jaw necrosis? Prolia (denosumab) can cause osteonecrosis of the jaw, a rare but serious side effect. This condition involves the death of bone tissue in the lower or upper jaw, often triggered by tooth extraction or other invasive dental procedures. Clinical trials and real-world data link it to denosumab's mechanism, which inhibits osteoclasts and slows bone remodeling. How common is jaw necrosis with Prolia? Incidence rates vary. Clinical trials reported rates below 1% for patients receiving denosumab, below 1% for patients receiving bisphosphonates, and below 1% for patients receiving placebo. The risk increases significantly among cancer patients receiving higher doses and after dental procedures. For osteoporosis patients, the risk remains low but rises with duration of treatment. Why does Prolia cause jaw necrosis? Denosumab works by targeting the RANKL pathway to block bone resorption. This interferes with normal bone turnover, leaving bone tissue unable to repair itself after minor injuries. Jaw bone is particularly vulnerable because it has high turnover rates and frequent exposure to oral microflora. Many cases report onset after dental extraction. What happens if you need a dental procedure while on Prolia? Patients should inform their dentist and doctor before undergoing any invasive work. Doctors often recommend delaying Prolia injections until after soft tissue healing, or referring patients to oral surgeons familiar with denosumab-related risks. Dental clearance before starting Prolia is also recommended. Can patients develop jaw necrosis after stopping Prolia? Cases occur both during treatment and after discontinuation. Bone effects persist for several months after the last injection, so the risk window extends beyond the physical presence of the drug in the body. Can biosimilars of Prolia trigger the same side effect? Yes. Biosimilars share the same active ingredient and same risk profile. Any denosumab product should carry the same warnings for osteonecrosis of the jaw. What alternatives exist if jaw necrosis develops? Treatment involves stopping the drug, antibiotics, pain management, and limited surgical debridement. No specific antidote exists.
Other Questions About Prolia :